Ingmar Bruns

5.4k citations

80 papers · 3.8k indexed · 3 hit papers · h-index 28

Impact in

Hematology top 0.2%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Multiple Myeloma Research and Treatments
Genetics top 0.5%
- Mesenchymal stem cell research

Papers in

Hematology 55
- Hematopoietic Stem Cell Transplantation 25
- Acute Myeloid Leukemia Research 20
- Multiple Myeloma Research and Treatments 18
- Chronic Myeloid Leukemia Treatments 11
- Platelet Disorders and Treatments 5
Genetics 19
- Chronic Lymphocytic Leukemia Research 10

Co-authors: Yuya Kunisaki Paul S. Frenette Sandra Pinho Daniel Lucas Christoph Scheiermann Toshihide Mizoguchi Aviv Bergman Jalal Ahmed
Journals: Blood (24 papers)Bone Marrow Transplantation (5 papers)Leukemia (4 papers)Haematologica (3 papers)Annals of Oncology (3 papers)
Partner nations: Germany United States United Kingdom

In The Last Decade

Ingmar Bruns

78 papers receiving 3.8k citations

Hit Papers

align trajectories log scale

Megakaryocytes regulate hematopoietic stem cell quiescence through CXCL4 secretion 2014 · 452 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2014 Nature Medicine
2013 Nature
2013 The Journal of Experimental Medicine

Peers

Countries citing papers authored by Ingmar Bruns

Since Specialization

Citations

This map shows the geographic impact of Ingmar Bruns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingmar Bruns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingmar Bruns more than expected).

Fields of papers citing papers by Ingmar Bruns

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingmar Bruns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingmar Bruns. The network helps show where Ingmar Bruns may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ingmar Bruns, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ingmar Bruns Line = papers co-authored together Ingmar Bruns links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A phase I/II study of maplirpacept in combination with pegylated liposomal doxorubicin (PLD) in patients with platinum-resistant ovarian cancer (OC): Phase 1 results. Journal of Clinical Oncology ·Daron Street, A. Manten, David Starks, Haider Mahdi, Carlos Linn, Dmitri Pavlov, D. Sanchez Gonzalo, Sant P. Chawla, Ingmar Bruns, Steven Waggoner	2024	2
2	525O A phase I dose escalation study of PRS-343, a HER2/4-1BB bispecific molecule, in patients with HER2-positive malignancies Annals of Oncology ·Geoffrey Y. Ku, A. Mtira, A. W. Tolcher, Sara A. Hurvitz, Anuradha Krishnamurthy, Anthony B. El-Khoueiry, Amita Patnaik, Rachna T. Shroff, Anne M. Noonan, Noah M. Hahn, Marc Matrana, Markus Zettl, Emilly Saas Alves, V. S. Zhamurova, P. Carniti, Shane A. Olwill, Ingmar Bruns, Sarina A. Piha‐Paul	2020	26
3	Megakaryocytes regulate hematopoietic stem cell quiescence via CXCL4 secretion Experimental Hematology ·Ingmar Bruns, Daniel Lucas, Sandra Pinho, Jalal Ahmed, Michele P. Lambert, Yuya Kunisaki, Christoph Scheiermann, Mortimer Poncz, جهاد بن عابد بن سعد القرعان, Paul S. Frenette	2014	2
4	Platelet Proteome Analysis Reveals Integrin-dependent Aggregation Defects in Patients with Myelodysplastic Syndromes Molecular & Cellular Proteomics ·Julia Fröbel, Ron‐Patrick Cadeddu, Sonja Hartwig, Ingmar Bruns, C. Matthias Wilk, Andrea Kündgen, Johannes Fischer, Thomas Schroeder, Ulrich Steidl, Ulrich Germing, Stefan Lehr, Rainer Haas, Akos Czibere	2013	30
5	Upfront Allogeneic Blood Stem Cell Transplantation for Patients with High-Risk Myelodysplastic Syndrome or Secondary Acute Myeloid Leukemia Using a FLAMSA-Based High-Dose Sequential Conditioning Regimen Biology of Blood and Marrow Transplantation ·嶺次郎鳥羽, Thomas Schroeder, Fabian Zohren, С.М. Кот, Ingmar Bruns, Akos Czibere, 赵水林, Mustafa Kondakci, Ísis Suzanne Crisóstomo Santos São Mateus, Roland Fenk, Ulrich Germing, Rainer Haas, Guido Kobbe	2011	32
6	Efficacious Immune Therapy in Chronic Myelogenous Leukemia (CML) Recognizes Antigens That Are Expressed on CML Progenitor Cells Cancer Research ·Melinda A. Biernacki, Ovidiu Marina, Wandi Zhang, Fenglong Liu, Ingmar Bruns, Ann Cai, Donna Neuberg, Christine Canning, Edwin P. Alyea, Robert J. Soiffer, Vladimir Brusić, Jerome Ritz, Catherine J. Wu	2010	43
7	Sorafenib Treatment in 13 Patients with Acute Myeloid Leukemia and Activating FLT3 Mutations in Combination with Chemotherapy or as Monotherapy Acta Haematologica ·Thomas Schroeder, Fabian Zohren, 嶺次郎鳥羽, Ingmar Bruns, Akos Czibere, Priti Mahalanobis, Roland Fenk, Rainer Haas, Guido Kobbe	2010	12
8	A 3-day short course of palifermin before HDT reduces toxicity and need for supportive care after autologous blood stem-cell transplantation in patients with multiple myeloma Annals of Oncology ·Guido Kobbe, Ingmar Bruns, Thomas Schroeder, Akos Czibere, Rajeev Kaushik, Oscar Torres Rodriguez, Nila Aguirre Gamarra, Mustafa Kondakci, 嶺次郎鳥羽, Ulrich Germing, Rainer Haas, Roland Fenk	2010	19
9	Esophageal cancer proliferation is mediated by cytochrome P450 2C9 (CYP2C9) Prostaglandins & Other Lipid Mediators ·Moritz Schmelzle, Levent Dizdar, Hanno Matthaei, Stephan Baldus, Mela Darmayanti, 一宏石井, Ingmar Bruns, Ron‐Patrick Cadeddu, Shu Ai Li, Stefan A. Topp, Jan Schulte Am Esch, Claus Ferdinand Eisenberger, Wolfram Trudo Knoefel, Nikolas H. Stoecklein	2010	24
10	Effect of the nonpeptide thrombopoietin receptor agonist Eltrombopag on bone marrow cells from patients with acute myeloid leukemia and myelodysplastic syndrome Blood ·Britta Will, Masahiro Kawahara, Hui Lei, Ingmar Bruns, Samir Parekh, Connie L. Erickson‐Miller, Manuel Aivado, Amit Verma, Ulrich Steidl	2009	95
11	5-Azacytidine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome who relapse after allo-SCT: a retrospective analysis Bone Marrow Transplantation ·Akos Czibere, Ingmar Bruns, Nicolaus Kröger, Uwe Platzbecker, Yaxin Miao, Fabian Zohren, Roland Fenk, Ulrich Germing, T. Schröder, Thorsten Gräf, Rainer Haas, Guido Kobbe	2009	75
12	Fludarabine, amsacrine, high-dose cytarabine and 12 Gy total body irradiation followed by allogeneic hematopoietic stem cell transplantation is effective in patients with relapsed or high-risk acute lymphoblastic leukemia Bone Marrow Transplantation ·Fabian Zohren, Akos Czibere, Ingmar Bruns, Roland Fenk, Thomas Schroeder, Thorsten Gräf, Rainer Haas, Guido Kobbe	2009	11
13	Pegfilgrastim for PBSC mobilization and autologous haematopoietic SCT Bone Marrow Transplantation ·Guido Kobbe, Ingmar Bruns, Roland Fenk, Akos Czibere, Rainer Haas	2009	21
14	Spastische Paraparese bei Morbus Scheuermann Zeitschrift für Orthopädie und ihre Grenzgebiete ·Ingmar Bruns, U. Heise	2008	2
15	Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor Haematologica ·Ingmar Bruns, Ulrich Steidl, Johannes Fischer, Akos Czibere, Guido Kobbe, Silja Raschke, Raminder Singh, Roland Fenk, L. Andy Chen, Sabrina Pechtel, Arndt von Haeseler, Peter Wernet, Daniel G. Tenen, Rainer Haas, Ralf Kronenwett	2008	29
16	Molecular signature of CD34+ hematopoietic stem and progenitor cells of patients with CML in chronic phase Leukemia ·成恒三宅, Ingmar Bruns, Frank Neumann, Johannes Fischer, Thorsten Graef, Ruth Way, Benedikt Brors, Sabrina Pechtel, Simone Bork, Annemarie Koch, In-Kyu Kang, О. А. Волошина, Guido Kobbe, Arndt von Haeseler, Norbert Gattermann, Rainer Haas, Ralf Kronenwett	2007	113
17	Sustained G-CSF plasma levels following administration of pegfilgrastim fasten neutrophil reconstitution after high-dose chemotherapy and autologous blood stem cell transplantation in patients with multiple myeloma Experimental Hematology ·Roland Fenk, Oscar Torres Rodriguez, Ulrich Steidl, Ingmar Bruns, Thorsten Graef, Fabian Zohren, Miguel Ángel Yebra Ferro, Rainer Haas, Guido Kobbe	2006	20
18	A potential novel strategy to separate therapeutic- and side-effects that are mediated via the same receptor: beta-arrestin2/G-protein coupling antagonists Journal of Clinical Pharmacy and Therapeutics ·Ingmar Bruns, Stephanie Psaki, CI Mesia, Hans Wilhelm Doerr, N. Ray Dunn, Hillary Smith, Lundberg T, M. A. Franscziskowski, 昌宏脇田, Cathy Reed, Robert B. Raffa	2006	12
19	Essential role of Jun family transcription factors in PU.1 knockdown–induced leukemic stem cells Nature Genetics ·Ulrich Steidl, Frank Rosenbauer, Roel G.W. Verhaak, Xuesong Gu, Alexander K. Ebralidze, Hasan H. Otu, Steffen Klippel, Christian Steidl, Ingmar Bruns, Daniel B. Costa, Katharina Wagner, Manuel Aivado, Guido Kobbe, Peter J.M. Valk, Emmanuelle Passegué, Towia A. Libermann, Ruud Delwel, Daniel G. Tenen	2006	132
20	Successful transplantation of peripheral blood stem cells mobilized by chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma Bone Marrow Transplantation ·Ulrich Steidl, Roland Fenk, Ingmar Bruns, Frank Neumann, Mustafa Kondakci, J. Ernhold Hede, Thorsten Gräf, Wen You Zhu, Simone Bork, Ralf Kronenwett, Rainer Haas, Guido Kobbe	2004	68

About Ingmar Bruns

Ingmar Bruns is a scholar working on Hematology, Genetics, Oncology, Immunology and Allergy and Immunology, having authored 80 papers that have together received 3.8k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (25 papers), Acute Myeloid Leukemia Research (20 papers), Multiple Myeloma Research and Treatments (18 papers), Chronic Myeloid Leukemia Treatments (11 papers), Chronic Lymphocytic Leukemia Research (10 papers), Cancer Treatment and Pharmacology (8 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Platelet Disorders and Treatments (5 papers). The work is most often cited by research in Hematology (2.5k citations), Genetics (1.1k citations), Immunology (969 citations), Oncology (892 citations) and Emergency Medicine (154 citations). Ingmar Bruns has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Yuya Kunisaki, Paul S. Frenette, Sandra Pinho, Daniel Lucas, Christoph Scheiermann, Toshihide Mizoguchi, Aviv Bergman, Jalal Ahmed, Guido Kobbe and Rainer Haas. Their work appears in journals such as Blood, Bone Marrow Transplantation, Leukemia, Haematologica and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact